Literature DB >> 29440387

The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.

Yutaka Kawakami1, Yuji Kurihara1, Yu Saito1, Yuki Fujita2, Toshihide Yamashita2, Kohtaro Takei3.   

Abstract

Nogo receptor type 1 (NgR1) is known to inhibit neuronal regeneration in the CNS. Previously, we have shown that lateral olfactory tract usher substance (LOTUS) interacts with NgR1 and inhibits its function by blocking its ligand binding. Therefore, LOTUS is expected to have therapeutic potential for the promotion of neuronal regeneration. However, it remains unknown whether the soluble form of LOTUS (s-LOTUS) also has an inhibitory action on NgR1 function as a candidate for therapeutic agents. Here, we show that s-LOTUS inhibits NgR1-mediated signaling by inhibiting the molecular interaction between NgR1 and its coreceptor, p75 neurotrophin receptor (p75NTR). In contrast to the membrane-bound form of LOTUS, s-LOTUS did not block ligand binding to NgR1. However, we identified p75NTR as a novel LOTUS binding partner and found that s-LOTUS suppressed the interaction between p75NTR and NgR1. s-LOTUS inhibited myelin-associated inhibitor (MAI)-induced RhoA activation in murine cortical neurons. Functional analyses revealed that s-LOTUS inhibited MAI-induced growth cone collapse and neurite outgrowth inhibition in chick DRG neurons. In addition, whereas olfactory bulb neurons of lotus-KO mice are sensitive to MAI due to a lack of LOTUS expression, treatment with s-LOTUS inhibited MAI-induced growth cone collapse in these neurons. Finally, we observed that s-LOTUS promoted axonal regeneration in optic nerve crush injury of mice (either sex). These findings suggest that s-LOTUS inhibits NgR1-mediated signaling, possibly by interfering with the interaction between NgR1 and p75NTR Therefore, s-LOTUS may have potential as a therapeutic agent for neuronal regeneration in the damaged CNS.SIGNIFICANCE STATEMENT Nogo receptor type 1 (NgR1) is a receptor well known to inhibit neuronal regeneration in the CNS. Because the membrane-bound form of lateral olfactory tract usher substance (LOTUS) antagonizes NgR1 through a cis-type molecular interaction between LOTUS and NgR1, the soluble form of LOTUS (s-LOTUS) is expected to be a therapeutic agent for neuronal regeneration. In our present study, we show that s-LOTUS inhibits the interaction between NgR1 and p75NTR, NgR1 ligand-induced RhoA activation, growth cone collapse, and neurite outgrowth inhibition and promotes axonal regeneration. Our results indicate that s-LOTUS inhibits NgR1-mediated signaling through a trans-type molecular interaction between LOTUS and NgR1 and, therefore, s-LOTUS may have therapeutic potential for neuronal regeneration.
Copyright © 2018 the authors 0270-6474/18/382589-16$15.00/0.

Entities:  

Keywords:  LOTUS; Nogo receptor; antagonist; regeneration

Mesh:

Substances:

Year:  2018        PMID: 29440387      PMCID: PMC6705898          DOI: 10.1523/JNEUROSCI.0953-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  Lateral olfactory tract usher substance (LOTUS) protein, an endogenous Nogo receptor antagonist, converts a non-permissive to permissive brain environment for axonal regrowth.

Authors:  Tomoko Hirokawa; Kohtaro Takei
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

Review 2.  Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?

Authors:  Min Joung Kim; Jung Hee Kang; Paschalis Theotokis; Nikolaos Grigoriadis; Steven Petratos
Journal:  Cells       Date:  2018-12-20       Impact factor: 6.600

3.  B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF.

Authors:  Maha M Bakhuraysah; Paschalis Theotokis; Jae Young Lee; Amani A Alrehaili; Pei-Mun Aui; William A Figgett; Michael F Azari; John-Paul Abou-Afech; Fabienne Mackay; Christopher Siatskas; Frank Alderuccio; Stephen M Strittmatter; Nikolaos Grigoriadis; Steven Petratos
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.996

4.  LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.

Authors:  Shuhei Ito; Narihito Nagoshi; Yasuhiro Kamata; Kota Kojima; Satoshi Nori; Morio Matsumoto; Kohtaro Takei; Masaya Nakamura; Hideyuki Okano
Journal:  Stem Cell Reports       Date:  2021-10-14       Impact factor: 7.765

Review 5.  Synaptic or Non-synaptic? Different Intercellular Interactions with Retinal Ganglion Cells in Optic Nerve Regeneration.

Authors:  Qi Zhang; Yiqing Li; Yehong Zhuo
Journal:  Mol Neurobiol       Date:  2022-03-09       Impact factor: 5.682

Review 6.  The CNS/PNS Extracellular Matrix Provides Instructive Guidance Cues to Neural Cells and Neuroregulatory Proteins in Neural Development and Repair.

Authors:  James Melrose; Anthony J Hayes; Gregory Bix
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

Review 7.  In vivo functions of p75NTR: challenges and opportunities for an emerging therapeutic target.

Authors:  Subash C Malik; Elif G Sozmen; Bernat Baeza-Raja; Natacha Le Moan; Katerina Akassoglou; Christian Schachtrup
Journal:  Trends Pharmacol Sci       Date:  2021-07-29       Impact factor: 17.638

Review 8.  Regulation of Macrophage and Dendritic Cell Function by Chondroitin Sulfate in Innate to Antigen-Specific Adaptive Immunity.

Authors:  Sonoko Hatano; Hideto Watanabe
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.